Muppidi, S., Guptill, J. T., Jacob, S., Li, Y., Farrugia, M. E., Guidon, A. C., … CARE-MG Study Group, . (2020). COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol, 19(12), 970–971. https://doi.org/10.1016/S1474-4422(20)30413-0

Muppidi, Srikanth, Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria E. Farrugia, Amanda C. Guidon, Jinny O. Tavee, et al. “COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).” Lancet Neurol 19, no. 12 (December 2020): 970–71. https://doi.org/10.1016/S1474-4422(20)30413-0.

Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, et al. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020 Dec;19(12):970–1.

Muppidi, Srikanth, et al. “COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).” Lancet Neurol, vol. 19, no. 12, Dec. 2020, pp. 970–71. Pubmed, doi:10.1016/S1474-4422(20)30413-0.

Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ, CARE-MG Study Group. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020 Dec;19(12):970–971.